Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Tax Provisions: 2023

Historic Tax Provisions for Foghorn Therapeutics (FHTX) over the last 1 years, with Dec 2023 value amounting to $2.0 million.

  • Foghorn Therapeutics' Tax Provisions was N/A to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $4.2 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Foghorn Therapeutics' Tax Provisions is $2.0 million, which was up 169.11% from $738,000 recorded in Q3 2023.
  • Foghorn Therapeutics' 5-year Tax Provisions high stood at $2.0 million for Q4 2023, and its period low was $560,000 during Q1 2023.
  • Moreover, its 1-year median value for Tax Provisions was $840,000 (2023), whereas its average is $1.1 million.